You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 129 No. 8, August 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  THE CUTTING EDGE
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (25)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Confluent and Reticulated Papillomatosis

Treatment With Etretinate

Samih A. Baalbaki, MD; John A. Malak, MD; Mohamed A.A. Al-Khars, MD, FRCPC

Arch Dermatol. 1993;129(8):961-963.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

REPORT OF CASES

Case 1

A 26-year-old obese Saudi Arabian man reported to the dermatology clinic with an itchy skin eruption of several years' duration. The patient's condition had been diagnosed as tinea versicolor and had failed to respond to several months of treatment with topical 1% clotrimazole cream or 2.5% selenium sulfide lotion. His family history was negative for any similar disease.

On dermatologic examination, hyperpigmented, reticulated scaly patches and plaques were present on the neck, back, sternal region, and antecubital fossae. The neck, axillae, and groin displayed lesions of acanthosis nigricans. On Wood's light examination only a faint yellow fluorescence could be detected. The potassium hydroxide smear was negative. The results of laboratory studies (complete blood cell count, urinalysis, serum electrolyte levels, renal and liver function tests, and serum cholesterol and triglyceride levels) were within normal limits.

He was treated with ketoconazole (200 mg twice a day) for . . . [Full Text PDF of this Article]


Author Affiliations

Saudi Aramco-Dhahran Health Center, Kingdom of Saudi Arabia



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.